This study is a retrospective chart review and entails review of medical records of patients enrolled in about 5 hospitals/clinics in China, and who have undergone breast augmentation or reconstruction with McGhan breast implants between 24 December 2015 and 31 December 2019. The safety of McGhan breast implants (textured and smooth) will be evaluated based on occurrence of local complications including capsular contracture, malposition of implant, seroma/late seroma and anaplastic large cell lymphoma (ALCL).
Study Type
OBSERVATIONAL
Enrollment
225
Beijing Lidu Plastic Surgery Hospital
Beijing, Beijing Municipality, China
Plastic Surgery Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Guangzhou Sogood Medical Cosmetology Hospital
Guangzhou, Guangdong, China
The Second People's Hospital of Guangdong Province
Guangzhou, Guangdong, China
Changsha Yan Han Medical Plastic Hospital
Changsha, Hunan, China
Hunan Yamei Medical Cosmetology Hospital
Changsha, Hunan, China
Number of participants who experienced adverse events
Time frame: up to 4 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.